I agree that this site is using cookies. You can find further informations here.
X
Lauring, Brett
40  results:
Search for persons X
?
1

Safety and efficacy of ertugliflozin in Asian patients with..:

Ji, Linong ; Liu, Yanmei ; Miao, Heng...
Diabetes, Obesity and Metabolism.  21 (2019)  6 - p. 1474-1482 , 2019
Link: https://doi.org/10.1111/..
 
?
2

Results of VERTIS SU extension study: safety and efficacy o..:

Hollander, Priscilla ; Hill, Julie ; Johnson, Jeremy...
Current Medical Research and Opinion.  35 (2019)  8 - p. 1335-1343 , 2019
Link: https://doi.org/10.1080/..
 
?
3

Long‐term efficacy and safety of ertugliflozin in patients ..:

Gallo, Silvina ; Charbonnel, Bernard ; Goldman, Allison...
Diabetes, Obesity and Metabolism.  21 (2019)  4 - p. 1027-1036 , 2019
Link: https://doi.org/10.1111/..
 
?
4

Ertugliflozin plus sitagliptin versus either individual age..:

Pratley, Richard E. ; Eldor, Roy ; Raji, Annaswamy...
Diabetes, Obesity and Metabolism.  20 (2018)  5 - p. 1111-1120 , 2018
Link: https://doi.org/10.1111/..
 
?
5

Design and baseline characteristics of the eValuation of ER..:

Cannon, Christopher P. ; McGuire, Darren K. ; Pratley, Richard...
American Heart Journal.  206 (2018)  - p. 11-23 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Long‐term efficacy and safety of ertugliflozin monotherapy ..:

Aronson, Ronnie ; Frias, Juan ; Goldman, Allison...
Diabetes, Obesity and Metabolism.  20 (2018)  6 - p. 1453-1460 , 2018
Link: https://doi.org/10.1111/..
 
?
7

Ertugliflozin Compared with Glimepiride in Patients with Ty..:

Hollander, Priscilla ; Liu, Jie ; Hill, Julie...
Diabetes Therapy.  9 (2017)  1 - p. 193-207 , 2017
Link: https://doi.org/10.1007/..
 
?
8

Effect of ertugliflozin on glucose control, body weight, bl..:

Rosenstock, Julio ; Frias, Juan ; Páll, Dénes...
Diabetes, Obesity and Metabolism.  20 (2017)  3 - p. 520-529 , 2017
Link: https://doi.org/10.1111/..
 
?
9

Efficacy and safety of the addition of ertugliflozin in pat..:

Dagogo‐Jack, Samuel ; Liu, Jie ; Eldor, Roy...
Diabetes, Obesity and Metabolism.  20 (2017)  3 - p. 530-540 , 2017
Link: https://doi.org/10.1111/..
 
?
10

Phase III, efficacy and safety study of ertugliflozin monot..:

Terra, Steven G. ; Focht, Kristen ; Davies, Melanie...
Diabetes, Obesity and Metabolism.  19 (2017)  5 - p. 721-728 , 2017
Link: https://doi.org/10.1111/..
 
?
11

Influence of renal and hepatic impairment on the pharmacoki..:

Lauring, Brett ; Li, Xiujiang (Susie) ; Liu, Yang...
The Journal of Clinical Pharmacology.  54 (2014)  11 - p. 1247-1255 , 2014
Link: https://doi.org/10.1002/..
 
?
12

Single therapeutic and supratherapeutic doses of anacetrapi..:

Lauring, Brett ; Liu, Yang ; Li, Xiujiang Susie...
The Journal of Clinical Pharmacology.  54 (2014)  7 - p. 765-775 , 2014
Link: https://doi.org/10.1002/..
 
?
13

(1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pen..:

Boatman, P. Douglas ; Lauring, Brett ; Schrader, Thomas O....
Journal of Medicinal Chemistry.  55 (2012)  8 - p. 3644-3666 , 2012
Link: https://doi.org/10.1021/..
 
?
14

Crystal structure of the human spastin AAA domain:

Taylor, Jennifer L. ; White, Susan Roehl ; Lauring, Brett.
Journal of Structural Biology.  179 (2012)  2 - p. 133-137 , 2012
Link: https://doi.org/10.1016/..
 
?
15

Laropiprant in Combination With Extended‐Release Niacin Doe..:

Lauring, Brett ; Dishy, Victor ; Luo, Wen‐Lin...
The Journal of Clinical Pharmacology.  49 (2009)  12 - p. 1426-1435 , 2009
Link: https://doi.org/10.1177/..
 
1-15